Clinical trial
Tacrolimus for the Treatment of Systemic Lupus Erythematosus With Membranous…
NCT00125307 · Chinese University of Hong Kong, Other · Completed
Key facts
| NCT number | NCT00125307 |
|---|---|
| Title | Tacrolimus for the Treatment of Systemic Lupus Erythematosus With Membranous Nephritis |
| Official title | Tacrolimus for the Treatment of Systemic Lupus Erythematosus With Membranous Nephritis |
| Lead sponsor | Chinese University of Hong Kong, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Lupus Nephritis, Lupus Erythematosus, Systemic |
| Intervention type | Drug |
| Interventions | tacrolimus |
| Enrollment | 20 |
| Start date | Jan 1, 2004 |
| Primary completion | Oct 1, 2007 |
| Completion | Feb 1, 2008 |
| First posted | Aug 1, 2005 |
| Last update posted | Aug 3, 2015 |
| Countries | Hong Kong |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: